BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35092398)

  • 21. Paracrine signalling of AGR2 stimulates RhoA function in fibroblasts and modulates cell elongation and migration.
    Mangukiya HB; Negi H; Merugu SB; Sehar Q; Mashausi DS; Yunus FU; Wu Z; Li D
    Cell Adh Migr; 2019 Dec; 13(1):332-344. PubMed ID: 31710263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect and mechanism of gene therapy of lentivirus mediated RhoA shRNA on ovarian cancer xenograft in vivo].
    Jiang WY; Kang JL; Wang XX; Yang WJ; Nie ML; Zhou C
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):778-83. PubMed ID: 24406137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells.
    Ishimoto T; Miyake K; Nandi T; Yashiro M; Onishi N; Huang KK; Lin SJ; Kalpana R; Tay ST; Suzuki Y; Cho BC; Kuroda D; Arima K; Izumi D; Iwatsuki M; Baba Y; Oki E; Watanabe M; Saya H; Hirakawa K; Baba H; Tan P
    Gastroenterology; 2017 Jul; 153(1):191-204.e16. PubMed ID: 28390866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of netrin-1 by hypoxia contributes to the invasion and migration of prostate carcinoma cells by regulating YAP activity.
    Chen H; Chen Q; Luo Q
    Exp Cell Res; 2016 Dec; 349(2):302-309. PubMed ID: 27815019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Correlation of expression of RhoA (RhoC and their effector ROCK-1 with malignant phenotype of ovarian cancer cells in vitro].
    Han ZQ; Zhang AL; Wu MF; Liu YL; Chen G; Li FJ; Gao QL; Liao GN; Lu YP; Wang SX; Ma D
    Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):385-8. PubMed ID: 15355639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 27. Activation of the RhoA-YAP-β-catenin signaling axis promotes the expansion of inner ear progenitor cells in 3D culture.
    Xia M; Chen Y; He Y; Li H; Li W
    Stem Cells; 2020 Jul; 38(7):860-874. PubMed ID: 32159914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian stromal cells as a source of cancer-associated fibroblasts in human epithelial ovarian cancer: A histopathological study.
    Fujisawa M; Moh-Moh-Aung A; Zeng Z; Yoshimura T; Wani Y; Matsukawa A
    PLoS One; 2018; 13(10):e0205494. PubMed ID: 30304016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. O-GlcNAcylation promotes migration and invasion in human ovarian cancer cells via the RhoA/ROCK/MLC pathway.
    Niu Y; Xia Y; Wang J; Shi X
    Mol Med Rep; 2017 Apr; 15(4):2083-2089. PubMed ID: 28259907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways.
    Yoshida GJ
    J Exp Clin Cancer Res; 2020 Jun; 39(1):112. PubMed ID: 32546182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma.
    Loria R; Laquintana V; Scalera S; Fraioli R; Caprara V; Falcone I; Bazzichetto C; Di Martile M; Rosanò L; Del Bufalo D; Bossi G; Sperduti I; Terrenato I; Visca P; Soddu S; Milella M; Ciliberto G; Falcioni R; Ferraresi V; Bon G
    J Exp Clin Cancer Res; 2022 Apr; 41(1):148. PubMed ID: 35440004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OTUB1 de-ubiquitinating enzyme promotes prostate cancer cell invasion in vitro and tumorigenesis in vivo.
    Iglesias-Gato D; Chuan YC; Jiang N; Svensson C; Bao J; Paul I; Egevad L; Kessler BM; Wikström P; Niu Y; Flores-Morales A
    Mol Cancer; 2015 Jan; 14(1):8. PubMed ID: 25623341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrative metabolic and transcriptomic profiling of prostate cancer tissue containing reactive stroma.
    Andersen MK; Rise K; Giskeødegård GF; Richardsen E; Bertilsson H; Størkersen Ø; Bathen TF; Rye M; Tessem MB
    Sci Rep; 2018 Sep; 8(1):14269. PubMed ID: 30250137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fascin is involved in cancer cell invasion and is regulated by stromal factors.
    Zhang X; Cho IH; Park JH; Lee MK; Hwang YS
    Oncol Rep; 2019 Jan; 41(1):465-474. PubMed ID: 30542700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RhoA/ROCK pathway mediates leptin-induced uPA expression to promote cell invasion in ovarian cancer cells.
    Ghasemi A; Hashemy SI; Aghaei M; Panjehpour M
    Cell Signal; 2017 Apr; 32():104-114. PubMed ID: 28104444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression.
    Shen T; Li Y; Zhu S; Yu J; Zhang B; Chen X; Zhang Z; Ma Y; Niu Y; Shang Z
    J Exp Clin Cancer Res; 2020 Feb; 39(1):36. PubMed ID: 32066485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of YAP protein in prostate cancer is associated with Gleason score increase.
    Hu X; Jia Y; Yu J; Chen J; Fu Q
    Tumori; 2015; 101(2):189-93. PubMed ID: 25908048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resveratrol suppresses breast cancer cell invasion by inactivating a RhoA/YAP signaling axis.
    Kim YN; Choe SR; Cho KH; Cho DY; Kang J; Park CG; Lee HY
    Exp Mol Med; 2017 Feb; 49(2):e296. PubMed ID: 28232662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stromal POSTN induced by TGF-β1 facilitates the migration and invasion of ovarian cancer.
    Yue H; Li W; Chen R; Wang J; Lu X; Li J
    Gynecol Oncol; 2021 Feb; 160(2):530-538. PubMed ID: 33317907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tenascin-C is a potential cancer-associated fibroblasts marker and predicts poor prognosis in prostate cancer.
    Ni WD; Yang ZT; Cui CA; Cui Y; Fang LY; Xuan YH
    Biochem Biophys Res Commun; 2017 May; 486(3):607-612. PubMed ID: 28341124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.